| Dr Christopher Michael Bean, MD | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-5101 | |
| Not Available |
| Full Name | Dr Christopher Michael Bean |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 17 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568658458 | NPI | - | NPPES |
| 04427852 | Medicaid | MS | |
| 2406868 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2088P0231X | Urology - Pediatric Urology | 23083 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Med Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that delays in the U.S. approval and launch of Theravance/Astellas's Vibativ (telavancin) for the treatment of nosocomial pneumonia will reduce by more than half the commercial impact that it was previously forecasted to garner in the methicillin-resistant Staphylococcus aureus (MRSA) drug market.
The simple intervention of providing women who are having unprotected sex with a home pregnancy test could have a substantial impact on the health of potential newborns, according to a Michigan State University study.
Researchers at Umea University have developed a model for evidence-based predictions of the mosquito-borne dengue virus. Results show that global travel and climate change increase the risk for epidemics of dengue, and potentially other climate-sensitive infectious diseases carried by mosquitos, spreading into temperate areas. This according to a doctoral dissertation at Umeå University.
In a world first, University of Sydney researchers from the ANZAC Research Institute at Concord Hospital, in collaboration with colleagues at Kings College London, have found a new gene abnormality that causes the fatal paralysis, motor neuron disease (MND).
› Verified 1 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that delays in the U.S. approval and launch of Theravance/Astellas's Vibativ (telavancin) for the treatment of nosocomial pneumonia will reduce by more than half the commercial impact that it was previously forecasted to garner in the methicillin-resistant Staphylococcus aureus (MRSA) drug market.
The simple intervention of providing women who are having unprotected sex with a home pregnancy test could have a substantial impact on the health of potential newborns, according to a Michigan State University study.
Researchers at Umea University have developed a model for evidence-based predictions of the mosquito-borne dengue virus. Results show that global travel and climate change increase the risk for epidemics of dengue, and potentially other climate-sensitive infectious diseases carried by mosquitos, spreading into temperate areas. This according to a doctoral dissertation at Umeå University.
In a world first, University of Sydney researchers from the ANZAC Research Institute at Concord Hospital, in collaboration with colleagues at Kings College London, have found a new gene abnormality that causes the fatal paralysis, motor neuron disease (MND).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Michael Bean, MD 2500 N State St, Jackson, MS 39216-4500 Ph: () - | Dr Christopher Michael Bean, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5101 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that delays in the U.S. approval and launch of Theravance/Astellas's Vibativ (telavancin) for the treatment of nosocomial pneumonia will reduce by more than half the commercial impact that it was previously forecasted to garner in the methicillin-resistant Staphylococcus aureus (MRSA) drug market.
The simple intervention of providing women who are having unprotected sex with a home pregnancy test could have a substantial impact on the health of potential newborns, according to a Michigan State University study.
Researchers at Umea University have developed a model for evidence-based predictions of the mosquito-borne dengue virus. Results show that global travel and climate change increase the risk for epidemics of dengue, and potentially other climate-sensitive infectious diseases carried by mosquitos, spreading into temperate areas. This according to a doctoral dissertation at Umeå University.
In a world first, University of Sydney researchers from the ANZAC Research Institute at Concord Hospital, in collaboration with colleagues at Kings College London, have found a new gene abnormality that causes the fatal paralysis, motor neuron disease (MND).
› Verified 1 days ago
Robert Tramel, Urology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 769-798-4747 | |
Dr. Mark Runnels, Urology Medicare: Accepting Medicare Assignments Practice Location: 1421 N State St, Ste 403, Jackson, MS 39202 Phone: 601-353-9900 Fax: 601-353-3654 | |
Dr. Michael Tyler Wood, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5101 | |
Dr. Kieran Hynes, MD Urology Medicare: Medicare Enrolled Practice Location: 501 Marshall St Ste 301, Jackson, MS 39202 Phone: 601-353-9900 | |
Ronald D Davis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr, Suite 360, Jackson, MS 39216 Phone: 601-200-4370 Fax: 601-200-4375 | |
Joe R. Ross, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1421 N State St, Suite 403, Jackson, MS 39202 Phone: 601-353-9900 Fax: 601-353-3654 | |
Deep Asit Gandhi, MD Urology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 |